← Eichor
Study identifier: NCT06592196 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Hepatic Safety of Statin Use in Neurology Inpatients

Condition: Statin Adverse Reaction  ·  Sponsor: Shanghai Yueyang Integrated Medicine Hospital

PhaseN/A
Planned participants2000
Who can joinAll sexes, 18 Years to 85 Years
Healthy volunteersNo

About this study

This research employs a cross-sectional study and a retrospective cohort study to analyze the liver safety of statin use among inpatients in the neurology department in China from different perspectives. The aim is to supplement evidence-based medicine and provide guidance for the clinical use of statins.

This description comes directly from the study's public registry record.

Talk to the study team

Contact details are listed per location below or on the registry record.

Always discuss trial participation with your own doctor first.

Locations (1)

Shanghai Yueyang Integrated Medicine HospitalShanghai, Shanghai Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06592196